China
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
China captures 49% of global drug deals in 2025 amidst lower costs, faster timelines
This is an improvement from only 6% in 2020.
Strong pipeline, M&A activity could trigger rapid earnings for Greater China's healthcare firms: UOB
The industry is expected to become a key international player.
China commands 30% of global biopharma pipeline; drives Asia’s share to 43%
The country transitions from fast follower to global innovation frontrunner.
Greater China healthcare keeps 'overweight' rating as R&D, biotech drive expansion
Outlook still positive despite trade and regulatory risks.
TAC-302 therapy seizes bladder cure market lead in China
This comes as the population ages and chronic conditions rise.
Perennial Holdings launches Healthcare City in Chongqing, China
Its first phase involves a total investment of approximately $212.8m (RMB1.5b).
China medical device market grows at 8.1% CAGR through 2029
High costs remain a challenge despite expanding digital adoption.
Two Shanghai hospitals sign MoU to strengthen clinical collaboration
The partnership follows the recent opening of Parkway MediCentre Xintiandi.
Parkway MediCentre Xintiandi in Shanghai
It is connected to Parkway Shanghai Hospital and the Parkway 百汇医疗 clinic network.
China's licensing boom reshapes global pharma power
Record-breaking BD deals reflect Beijing's innovative assets are gaining massive international recognition.
Why China's pharma market is now a consumer game
Stakeholders must understand this moment, as it signifies a fundamental shift in the industry.
China’s pharma growth shifts from drugs to high-tech manufacturing
However, there is still a lot of pressure in pharmaceutical manufacturing.
Perennial Holdings, Ruijin Hospital to build international medical platform
The partnership also includes a talent training and exchange programme.
Medical devices supply chains at risk as China tightens rare earth exports
Sectors most exposed include MRI and X-ray device production.
Melco launches integrated resort hospital at Studio City Macau
The new iRad Hospital offers MRI and CT scanning.
China’s healthcare sector raises $10.6b through equity offerings
Strong activity is expected to continue in the second half.
Perennial to launch Shanghai’s first wholly foreign-owned tertiary hospital
The project is expected to carry a total investment cost of $69.4m (RMB500m).
Most Read
1. New A1Health-MediExpress partnership streamlines patient care across 21 hospitals 2. Advances in digital imaging, nanotech drive microscopy market to $11.4b by 2031 3. Health Bureau pushes workforce expansion in MCHK reform plan 4. Health sterotypes block early preventative actions amongst Asians: AIA 5. Medical fibre optics to hit $1.5b by 2030 as minimally invasive surgery surgesResource Center
Read Here
Advertise
Sign Up
Events
Event News
Top leaders will discuss AI adoption in healthcare.
